Standout Papers

Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis 2001 2026 2009 2017 806
  1. Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis (2006)
    Ludwig Kappos, Jack P. Antel et al. New England Journal of Medicine
  2. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study (2001)
    Giancarlo Comi, Massimo Filippi et al. The Lancet
  3. European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadian Glatiramer Acetate Study Group. (2001)
    Giancarlo Comi, Massimo Filippi et al. PubMed

Immediate Impact

12 from Science/Nature 103 standout
Sub-graph 1 of 16

Citing Papers

Multiple sclerosis
2023 Standout
Human temperature regulation under heat stress in health, disease, and injury
2022 Standout
43 intermediate papers

Works of Giancarlo Comi being referenced

Stopping disease-modifying therapy in relapsing and progressive multiple sclerosis
2021
Somatosensory evoked potentials and sensory involvement in multiple sclerosis: comparison with clinical findings and quantitative sensory tests
2003
and 41 more

Author Peers

Author Last Decade Papers Cites
Giancarlo Comi 10443 3606 3896 226 14.1k
Marco Rovaris 8775 2756 3524 300 11.8k
Jeroen J.G. Geurts 11224 4258 3243 233 16.3k
Rohit Bakshi 9040 2502 3754 259 13.8k
Àlex Rovira 8191 3173 4931 403 15.7k
Vittorio Martinelli 7698 1706 3448 273 10.6k
Robert Zivadinov 12436 2914 5569 575 18.8k
David MacManus 6381 2167 3255 145 10.2k
Carlo Pozzilli 9882 1832 4046 376 14.6k
Bernard M.J. Uitdehaag 11716 2294 3960 453 18.1k
Maria Pia Sormani 9549 2623 4342 415 16.5k

All Works

Loading papers...

Rankless by CCL
2026